LB Pharmaceuticals, Inc. (LBRX)
28.39
-0.88
(-3.01%)
USD |
NASDAQ |
Jun 10, 16:00
27.49
-0.90
(-3.17%)
Pre-Market: 20:00
LB Pharmaceuticals EPS Diluted (TTM) : -1.486 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | -1.486 |
| December 31, 2025 | -1.021 |
| September 30, 2025 | -0.7933 |
| June 30, 2025 | -1.285 |
| March 31, 2025 | -2.302 |
| Date | Value |
|---|---|
| December 31, 2024 | -2.812 |
| September 30, 2024 | -2.735 |
| June 30, 2024 | -2.103 |
| March 31, 2024 | -0.8687 |
| March 31, 2023 | -0.1489 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| NRX Pharmaceuticals, Inc. | -1.278 |
| Alto Neuroscience, Inc. | -2.482 |
| ANI Pharmaceuticals, Inc. | 3.942 |
| Corcept Therapeutics, Inc. | 0.35 |
| Assertio Holdings, Inc. | -5.733 |